AOC3 and early-onset autosomal dominant Alzheimer disease: VAP-1's involvement in the pathogenesis of numerous conditions, such as rheumatoid arthritis, chronic liver inflammation and fibrosis, neuroinflammatory diseases, Parkinson's disease, Alzheimer's disease, and cancer, highlights its importance as a therapeutic target in the pharmaceutical industry (131, 159–164).